A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill

Critical Care Medicine

Volumn 26, Issue 7, 1998, Pages 1164-1172

  Atkinson, Simon ^a   Sieffert, Edith ^a   Bihari, David ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Arginine; Duration of ventilation; Early enteral nutrition; ICU outcome; Immunonutrition; Impact ; Length of hospital stay; Omega 3 fatty acids; Purine nucleotides; Systemic inflammatory response syndrome

Indexed keywords

AMINO ACID METABOLISM; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIET SUPPLEMENTATION; ENTERIC FEEDING; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MORTALITY; NUTRIENT; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0031813383     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199807000-00013     Document Type: Article

References (38)

1. Moore FA, Feliciano DV, Andrassy RJ, et al: Early enterai feeding, compared with parenteral, reduces septic post-operative complications. The results of a meta-analysis. Ann Surg 1992; 216:172-183
2. Bower RH, Talamini MA, Sax HC, et al: Postoperative enterai vs. parenteral nutrition. Arch Surg 1986; 21: 1040-1045
3. Kudsk KA, Croce MA, Fabian TC, et al: Enteral versus parenteral feeding: Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992; 215:503-511
4. McClave SA, Lowen CC, Snider HL: Immunonutrition and enterai hyperalimentation of critically ill patients. Dig Dis Sci 1992; 37:1153-1161
5. Cerra FB, Lehmann S, Konstantinides N, et al: Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition 1991; 7:193-199
6. Daly JM, Faith N, Weintraum MSN, et al: Enterai nutrition during multi-modality therapy in upper gastrointestinal cancer patients. Surgery 1995; 221:327-338
7. Bower RH, Cerra FB, Bershadsky B, et al: Early enterai administration of a formula (Impact®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449
8. Kirk SJ, Regan MC, Wasserkrug HL, et al: Arginine enhances T-cell responses in athymic nude mice. JPEN 1992; 16:429-432
9. Daly JM, Reynolds J, Thom A, et al: Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208:512-522
10. Wells CL, Jechorek RP, Erlandsen SL, et al: The effect of dietary glutamine and dietary RNA on ileal flora, ileal histology, and bacterial translocation in mice. Nutrition 1990; 6:70-75
11. Kulkarni AD, Fanslow WC, Rudolph FB, et al: Effect of dietary nucleotides on response to bacterial infections. JPEN 1986; 10:169-171
12. Billiar TR, Bankey PE, Svingen BA, et al: Fatty acid intake and Kupffer cell function: Fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988; 104: 343-349
13. Kinsella JE, Lokesh B, Broughton S, et al: Dietary polyunsaturated fatty acids and eicosanoids: Potential effects on the modulation of inflammatory and immune cells: An overview. Nutrition 1990; 6:24-44
14. Kemen M, Senkal M, Homann H-H, et al: Early postoperative enterai nutrition with arginine-ω-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: An immunologic evaluation of Impact®. Crit Care Med 1995; 23:652-659
15. Kudsk KA, Minard G, Croce MA, et al: A randomized trial of isonitrogenous enterai diets after severe trauma - An immune enhancing diet reduces septic complications. Ann Surg 1996; 224: 531-543
16. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
17. Keene RA, Cullen DJ: Therapeutic intervention scoring system: Update 1983. Crit Care Med 1983; 11:1-4
18. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
19. Fisher CJ, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334: 1697-1702
20. Fisher CJ, Dhainaut JF, Opal SM, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271:1836-1843
21. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995; 273:934-941
22. Atkinson S, Bihari D: Immunonutrition: We are what we eat. Gastroenterology 1996; 110:1676
23. Barbul A: Arginine and immune function. Nutrition 1990; 6:53-59
24. Barton RG, Cerra FB, Wells CL: Effect of a diet deficient in essential fatty acids on the translocation of intestinal bacteria. JPEN 1992; 16:122-128
25. Senkal M, Kemen M, Homann HH, et al: Modulation of postoperative immune response by enterai nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995; 161:115-122
26. Moore FA, Moore EE, Kudsk KA, et al: Clinical benefits of an immune-enhancing diet for early post injury enteral feeding. J Trauma 1994; 37:607-615
27. Kenler AS, Swails WS, Driscoll DF, et al: Early enterai feeding in postsurgical cancer patients: Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Surgery 1996; 223:316-333
28. Endres S, Ghorbani R, Kelley VE, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin 1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271
29. Grimble RF: Interaction between nutrients, pro-inflammatory cytokines and inflammation. Clin Sci 1996; 91:121-130
30. Dragsted L, Jorgenson J, Jensen N-H, et al: Interhospital comparisons of patient outcome from intensive care: Importance of lead-time bias. Crit Care Med 1989; 17:418-422
31. Knaus WA, Draper EA, Wagner DP, et al: The APACHE III prognostic system - Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
32. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS) - A prospective study. JAMA 1995; 273:117-123
33. Zaloga GP: Permissive underfeeding. New Horiz 1994; 2:257-263
34. Zhong Z, Jones S, Thurman RG: Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 1996; 270:G332-G338
35. Ikejima K, Iimuro Y, Forman DT, et al: A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol 1996; 271:G97-G103
36. Petros AJ, Marshall JC, van Saene HKF: Should morbidity replace mortality as an endpoint for clinical trials in intensive care? Lancet 1995; 345:369-371
37. Koretz RL: Selected summaries - The impact of immunonutrition. Gastroenterology 1995; 109:1713-1714
38. Frost P, Edwards N, Bihari D: Gastric emptying in the critically ill - The way forward? Intensive Care Med 1997; 23:243-245